Reply
 
Thread Tools Display Modes
Old 06-24-2008, 05:38 PM #31
jackD's Avatar
jackD jackD is offline
Member
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
jackD jackD is offline
Member
jackD's Avatar
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
Default NGF - Calcium - The Degenerative Stage of MS

Numerous neurotrophic growth factors help determine which neurons develop in the immature brain and which are retained in the adult brain.

Neurotrophic factors can also induce neurons to sprout axons capable of growing into new locations and forming new synaptic connections, a process that continues in the mature brain.

NGF (Nerve Growth Factor) is one essential neurotrophic growth factor. The below links describe how calcium is used in this process and how Glutamate toxicity kills neurons using Calcium in the Second stage of MS.


http://www.psychiatrist.com/pcc/brainstorm/br5904.htm (main article)

http://www.psychiatrist.com/pcc/brainstorm/br5906.htm (therapeutic potential)

http://www.psychiatrist.com/pcc/brainstorm/br5806.htm (Glutamate assassin/excitotoxic neuron murder)

The Second Stage of MS is "The Degenerative Stage" in which "excess Glutamate" runs wild on a killing spree. First phase, of course, is the "Inflammatory Stage" of MS.

http://home.ix.netcom.com/~jdalton/ms-two-stages.pdf

jackD

Last edited by jackD; 06-24-2008 at 07:20 PM.
jackD is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
Dejibo (06-24-2008), starfish (06-24-2008)
Old 06-24-2008, 07:10 PM #32
Kristi's Avatar
Kristi Kristi is offline
Member
 
Join Date: Jan 2008
Location: Metro detroit area of Michigan
Posts: 200
15 yr Member
Kristi Kristi is offline
Member
Kristi's Avatar
 
Join Date: Jan 2008
Location: Metro detroit area of Michigan
Posts: 200
15 yr Member
Default

Quote:
Originally Posted by jackD View Post
Numerous neurotrophic growth factors help determine which neurons develop in the immature brain and which are retained in the adult brain.

Neurotrophic factors can also induce neurons to sprout axons capable of growing into new locations and forming new synaptic connections, a process that continues in the mature brain.

NGF (Nerve Growth Facto)r is one essential neurotrophic growth factor. The below links describe how calcium is used in this process and how Glutamate toxicity kills neurons using Calcium in the Second stage of MS.


http://www.psychiatrist.com/pcc/brainstorm/br5904.htm (main article)

http://www.psychiatrist.com/pcc/brainstorm/br5906.htm (therapeutic potential)

http://www.psychiatrist.com/pcc/brainstorm/br5806.htm (Glutamate assassin/excitotoxic neuron murder)

The Second Stage of MS is "The Degererative Stage" in which "excess Glutamate" runs wild on a killing spree. First phase, of course, is the "Inflammatory Stage" of MS.

http://home.ix.netcom.com/~jdalton/ms-two-stages.pdf

jackD

Thanks, Jack for all your good information on the subject.
__________________
Diagnosed Probable MS 9/21/07
.

Started Copaxone 10/16/07


3-6-9 the goose drank wine the monkey chewed tobacoo on the street car line the line broke the monkey got choked and they all went to heaven in a little row boat...
.
Kristi is offline   Reply With QuoteReply With Quote
Old 06-24-2008, 08:21 PM #33
starfish starfish is offline
Member
 
Join Date: May 2008
Location: NY
Posts: 166
15 yr Member
starfish starfish is offline
Member
 
Join Date: May 2008
Location: NY
Posts: 166
15 yr Member
Default

Hi jackD! You are making want to go to the library and get a biochem book!! I am sure I got rid of my college book when it was 25 years old.

I am concerned that NGF also influences the activity of B and T cells. I would have to understand how a little better.

I did find vitamin D3 at BJs Wholesale Club in 1000 IU capsules. I understand why we may need more.

I very much liked your last link because it had the best graphic explaining the nerve issues with the chemicals and how Copaxone works in certain situations.If anyone has a little knowledge about biochem you really should take a peek.

I don't know how you are finding this material, in its complete form, but I am glad you are sharing it. Its not easy to find more than just an abstract.

I know that our dendrites can grow and elongate,

http://www-als.lbl.gov/als/science/s...9receptor.html

and that is why my neuro told me about Wii actually helping to grow these for folks who can't get enough activity outside of the home.

So to keep this back to Vitamin D, it supports the NGF, if I am interpretting this properly.
starfish is offline   Reply With QuoteReply With Quote
Old 06-24-2008, 08:31 PM #34
jackD's Avatar
jackD jackD is offline
Member
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
jackD jackD is offline
Member
jackD's Avatar
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
Default

Quote:
Originally Posted by starfish View Post
Hi jackD! You are making want to go to the library and get a biochem book!! I am sure I got rid of my college book when it was 25 years old.

I am concerned that NGF also influences the activity of B and T cells. I would have to understand how a little better.

I did find vitamin D3 at BJs Wholesale Club in 1000 IU capsules. I understand why we may need more.

I very much liked your last link because it had the best graphic explaining the nerve issues with the chemicals and how Copaxone works in certain situations.If anyone has a little knowledge about biochem you really should take a peek.

I don't know how you are finding this material, in its complete form, but I am glad you are sharing it. Its not easy to find more than just an abstract.

I know that our dendrites can grow and elongate,

http://www-als.lbl.gov/als/science/s...9receptor.html

and that is why my neuro told me about Wii actually helping to grow these for folks who can't get enough activity outside of the home.

So to keep this back to Vitamin D, it supports the NGF, if I am interpretting this properly.
THANKS!!

You are right about the Vit D and NGF connection.

That techie site...

http://www.copewithcytokines.de/cope.cgi?key=NGF

says that ...
Quote:
Serum, phorbol 12-myristate 13-acetate (see also: Phorbol esters), and vitamin D3 are potent inducers of NGF synthesis. Glucocorticoids inhibit the synthesis of NGF.
.

That comment about Glucocorticoids (STEROIDS) blocking NGF production is a real bummer.

jackD
jackD is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
starfish (06-26-2008)
Old 06-24-2008, 08:54 PM #35
jackD's Avatar
jackD jackD is offline
Member
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
jackD jackD is offline
Member
jackD's Avatar
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
Default idebenone - NGF

I also take some IDEBENONE to get some extra NGF production in my brain. It is a bit expensive and you need to take 2 caps daily.

jackD

p.s. It a modified form of CQ-10 and is somewhat difficult to find in stores. I hear the rats love the stuff. I can now make it thru the water maze in a flash.

Quote:
1: Naunyn Schmiedebergs Arch Pharmacol. 1994 Apr;349(4):401-7.

Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats.

Nitta A, Murakami Y, Furukawa Y, Kawatsura W, Hayashi K, Yamada K, Hasegawa T, Nabeshima T.

Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University School of Medicine, Japan.

Nerve growth factor plays an important role in the survival and maintenance of cholinergic neurons in the central neuronal system. In senile dementia of the Alzheimer type, learning and memory are impaired by the loss of neurons in the magnocellular cholinergic neuronal system.

It is therefore, of interest to investigate the role of nerve growth factor in this degenerative disorder.

Since nerve growth factor does not cross the blood-brain barrier and is easily metabolized by peptidases when administered peripherally, it can be used for medical treatment only when directly injected into the brain.

We demonstrate here that the oral administration of idebenone, a potent in vitro nerve growth factors synthesis stimulator, induced an increase in nerve growth factor protein and mRNA, and in choline acetyltransferase activity, in basal forebrain lesioned rats, but not in intact rats.

Idebenone also ameliorated the behavioral deficits in habituation, water maze, and passive avoidance tasks in these animals.

These results suggest that idebenone stimulated nerve growth factor synthesis in vivo and ameliorates the behavioral deficits which were accompanied with the recovery of the reduced choline acetyltransferase activity in the basal forebrain-lesioned rats.

PMID: 8058112 [PubMed - indexed for MEDLINE]
Quote:
1: Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):27-32.Links
[Noben (idebenone) in the treatment of dementia and memory impairment without dementia][Article in Russian]


[No authors listed]
Noben (idebenone) was administered in dosage 120 mg during 6 months to 35 patients, aged from 60 to 86 years, with dementia, Alzheimer's type and mixed type, and with memory disturbances which did not reach the level of dementia. The assessment of patient's state before and after treatment was based on the results of somatic, neurological and psychiatric examination as well as neuropsychological testing and using of psychometrical and other scales. The significant improvement on the MMSE scale was found in patients with mild and moderate dementia.

The improvement of daily activity was observed in 27% of patients. The neuropsychological study revealed the improvement of short-term and delayed memory and attention, speech functions, the performance on kinesthetic, spatial and dynamic praxis tests, visual-spatial gnosis, reasoning and writing.

The positive therapeutic effect assessed by the CGI scale was observed in 37% of patients, the stable state--in 48%.

PMID: 18454094 [PubMed - in process]

Last edited by jackD; 06-25-2008 at 10:56 AM.
jackD is offline   Reply With QuoteReply With Quote
Old 06-25-2008, 10:53 AM #36
jackD's Avatar
jackD jackD is offline
Member
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
jackD jackD is offline
Member
jackD's Avatar
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
Default Other reason for taking Vit (K1 & K2) combo

Not a bad side effect for something that stops/removes excess calcium deposits from Vit D/calcium supplementing.

jackD


Quote:
1: J Neurosci. 2003 Jul 2;23(13):5816-26.

Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons.

Li J, Lin JC, Wang H, Peterson JW, Furie BC, Furie B, Booth SL, Volpe JJ, Rosenberg PA.
Department of Neurology, Division of Neuroscience, Children's Hospital, Boston, MA 02115, USA.

Oxidative stress is believed to be the cause of cell death in multiple disorders of the brain, including perinatal hypoxia/ischemia.

Glutamate, cystine deprivation, homocysteic acid, and the glutathione synthesis inhibitor buthionine sulfoximine all cause oxidative injury to immature neurons and oligodendrocytes by depleting intracellular glutathione.

Although vitamin K is not a classical antioxidant, we report here the novel finding that vitamin K1 and K2 (menaquinone-4) potently inhibit glutathione depletion-mediated oxidative cell death in primary cultures of oligodendrocyte precursors and immature fetal cortical neurons with EC50 values of 30 nm and 2 nm, respectively. The mechanism by which vitamin K blocks oxidative injury is independent of its only known biological function as a cofactor for gamma-glutamylcarboxylase, an enzyme responsible for posttranslational modification of specific proteins. Neither oligodendrocytes nor neurons possess significant vitamin K-dependent carboxylase or epoxidase activity. Furthermore, the vitamin K antagonists warfarin and dicoumarol and the direct carboxylase inhibitor 2-chloro-vitamin K1 have no effect on the protective function of vitamin K against oxidative injury.

Vitamin K does not prevent the depletion of intracellular glutathione caused by cystine deprivation but completely blocks free radical accumulation and cell death.

The protective and potent efficacy of this naturally occurring vitamin, with no established clinical side effects, suggests a potential therapeutic application in preventing oxidative damage to undifferentiated oligodendrocytes in perinatal hypoxic/ischemic brain injury.

PMID: 12843286 [PubMed - indexed for MEDLINE
jackD is offline   Reply With QuoteReply With Quote
Old 06-25-2008, 01:59 PM #37
jackD's Avatar
jackD jackD is offline
Member
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
jackD jackD is offline
Member
jackD's Avatar
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
Default NGF & Vit K1 K2 & neurons

Interesting to see how NGF and the Vit Ks work together to protect and enhance neuron outgrowth.

jackD


Quote:
Neurosci Lett. 2002 Apr 19;323(1):9-12.

Novel effect of vitamin K(1) (phylloquinone) and vitamin K(2) (menaquinone) on promoting nerve growth factor-mediated neurite outgrowth from PC12D cells.

Tsang CK, Kamei Y.
Marine and Highland Bioscience Center, Saga University, 152-1 Shonan-cho, Karatsu, 847-0021, Saga, Japan.


The nerve growth factor (NGF)-potentiating effect of K vitamins on PC12D cells was investigated.

Treatment of PC12D cells with vitamin K(1) or K(2) in the presence of NGF significantly enhanced the proportion of neurite-bearing cells and acetylcholinesterase activity compared with NGF treatment alone.

The K vitamins-enhanced neurite outgrowth on PC12D cells was completely blocked by a protein kinase A (PKA) inhibitor or mitogen-activated protein kinase (MAPK) kinase inhibitor PD98059, whereas a protein kinase C inhibitor chelerythrine chloride did not significantly inhibit the enhancing effect of the K vitamins.

These results suggest that the K vitamins enhance neurite outgrowth via the activation of PKA and MAPK-mediated signaling pathways in PC12D cells.

PMID: 11911978 [PubMed - indexed for MEDLINE]
jackD is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
starfish (06-26-2008)
Old 06-25-2008, 03:15 PM #38
Bentnub Bentnub is offline
Junior Member
 
Join Date: Jun 2008
Posts: 9
15 yr Member
Bentnub Bentnub is offline
Junior Member
 
Join Date: Jun 2008
Posts: 9
15 yr Member
Default glutamate excitotoxicity

Neurologische Universitätsklinik, Robert-Koch-Strasse 40, D-37075 Göttingen, Germany.

Axonal destruction and neuronal loss occur early during multiple sclerosis, an autoimmune inflammatory CNS disease that frequently manifests with acute optic neuritis. Available therapies mainly target the inflammatory component of the disease but fail to prevent neurodegeneration. To investigate the effect of minocycline on the survival of retinal ganglion cells (RGCs), the neurons that form the axons of the optic nerve, we used a rat model of myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis. Optic neuritis in this model was diagnosed by recording visual evoked potentials and RGC function was monitored by measuring electroretinograms. Functional and histopathological data of RGCs and optic nerves revealed neuronal and axonal protection when minocycline treatment was started on the day of immunization. Furthermore, we demonstrate that minocycline-induced neuroprotection is related to a direct antagonism of multiple mechanisms leading to neuronal cell death such as the induction of anti-apoptotic intracellular signalling pathways and a decrease in glutamate excitotoxicity. From these observations, we conclude that minocycline exerts neuroprotective effects independent of its anti-inflammatory properties. This hypothesis was confirmed in a non-inflammatory disease model leading to degeneration of RGCs, the surgical transection of the optic nerve.

PMID: 17239606 [PubMed - indexed for MEDLINE]
Bentnub is offline   Reply With QuoteReply With Quote
Old 06-25-2008, 04:36 PM #39
jackD's Avatar
jackD jackD is offline
Member
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
jackD jackD is offline
Member
jackD's Avatar
 
Join Date: Jan 2008
Location: Maryland outside WASH DC
Posts: 258
15 yr Member
Default

Quote:
Originally Posted by Bentnub View Post
Neurologische Universitätsklinik, Robert-Koch-Strasse 40, D-37075 Göttingen, Germany.

Axonal destruction and neuronal loss occur early during multiple sclerosis, an autoimmune inflammatory CNS disease that frequently manifests with acute optic neuritis. Available therapies mainly target the inflammatory component of the disease but fail to prevent neurodegeneration. To investigate the effect of minocycline on the survival of retinal ganglion cells (RGCs), the neurons that form the axons of the optic nerve, we used a rat model of myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis. Optic neuritis in this model was diagnosed by recording visual evoked potentials and RGC function was monitored by measuring electroretinograms. Functional and histopathological data of RGCs and optic nerves revealed neuronal and axonal protection when minocycline treatment was started on the day of immunization. Furthermore, we demonstrate that minocycline-induced neuroprotection is related to a direct antagonism of multiple mechanisms leading to neuronal cell death such as the induction of anti-apoptotic intracellular signalling pathways and a decrease in glutamate excitotoxicity. From these observations, we conclude that minocycline exerts neuroprotective effects independent of its anti-inflammatory properties. This hypothesis was confirmed in a non-inflammatory disease model leading to degeneration of RGCs, the surgical transection of the optic nerve.

PMID: 17239606 [PubMed - indexed for MEDLINE]

THANKS!

Targeting "things" to reduce BOTH Inflammation and glutamate excitotoxicity makes a lot of sense.

I am not a fan of minocycline treatment because I feel that it's main benefit comes from reducing MMP-9s and the damage the MMP-9s do in the MS's destructive processes. I have been researching safe ways to reduce glutamate excitotoxicity via a number of common supplements.

I hope you realize that it is NOT the antibiotic nature of minocycline that provides its MS benefit. I would not take it or recommend taking it for a long period of time. There are better & safer alternatives.

jackD

Quote:
Breakthrough in research for multiple sclerosis (MS)
28 Oct 2004

Paratek Pharmaceuticals, Inc announced results of preclinical studies demonstrating that a new class of compounds, orally available non-antibacterial tetracyclines, has shown promising activity in a preclinical animal model of multiple sclerosis (MS). Affecting approximately two million people worldwide, MS is a chronic, inflammatory condition of the nervous system and the most common, non-traumatic, neurological disease in young adults. Dr. David McKenney, a Paratek scientist, will present the findings during an oral presentation at 2:30 p.m. PST (5:30 p.m. EST) today at Neuroscience 2004, the Society for Neuroscience's 34th Annual Meeting in San Diego.
For the first time, Paratek is presenting data showing that its non-antibacterial tetracycline compounds in a preclinical model of MS have efficacy comparable to minocycline, an antibiotic also in the tetracycline family. A previous clinical study directed by Dr. Luanne Metz at the University of Calgary has demonstrated disease protection in MS patients treated with minocycline. Unfortunately, long-term treatment with minocycline or any other broad-spectrum antibiotics causes many patients to experience intolerability related to antibiotic side effects. In today's presentation, Paratek will report that three non-antibacterial tetracycline compounds, with different structures, demonstrated activity in reducing limb paralysis in the preclinical EAE (Experimental Autoimmune Encephalomyelitis) model of MS. These compounds have no detectable antibacterial activity.

Paratek Pharmaceuticals, Inc. and Serono (virt-x: SEO and NYSE: SRA) announced today that they have entered into an agreement to discover, develop and commercialize an orally-available disease modifying treatment for multiple sclerosis (MS). The agreement covers the compounds for which Dr. McKenney presents data today.

Stuart Levy, Paratek's Vice Chairman, Chief Scientific Officer and Co-Founder, commented, "The clinical research community has long regarded a pill for MS as an ultimate goal, but so far attempts to develop a safe, feasible, orally available drug candidate have failed. Our team has successfully modified the tetracycline molecule, keeping the core structure that confers anti-MS activity while removing portions of the molecule with antibacterial effects. This represents an exciting advance not only for MS, but potentially for many other inflammation-related disease areas. "

Dr. Michael Draper, Associate Director at Paratek, stated, "Paratek has developed world-class expertise in modifying the tetracycline class, which has a 30-year track record in the marketplace and a favorable, well-documented safety profile. This new, proprietary class of non-antibacterial tetracycline compounds will avoid the negative consequences associated with long-term antibiotic use and will not further contribute to the development of antibiotic resistance. We believe that these highly active, orally available compounds will also prove to be well-tolerated for MS, and we are very proud of this accomplishment."

About Multiple Sclerosis

Multiple sclerosis is a chronic, inflammatory condition of the nervous system and is the most common non-traumatic neurological disease in young adults. Multiple sclerosis may affect approximately two million people worldwide. While symptoms can vary, the most common symptoms of multiple sclerosis include blurred vision, numbness or tingling in the limbs and problems with strength and coordination. The relapsing forms of multiple sclerosis are the most common.

About Paratek Pharmaceuticals
Paratek Pharmaceuticals, Inc. is engaged in the discovery and commercialization of new therapeutics that treat serious and life-threatening diseases, with a particular focus on the growing worldwide problem of antibiotic resistance. Paratek's lead programs are advancing novel compounds that can circumvent or block bacterial resistance, as well as drugs that can prevent infection by interfering with Multiple Adaptational Response (MAR) mechanisms in bacteria. Out of these efforts, Paratek has discovered a new class of antibiotics, the aminomethylcyclines that target the need for new and potent antibacterials to overcome the problem of rapidly growing bacterial resistance. The Company's lead antibiotic clinical candidate, BAY 73-7388, the first product from this class, is being developed in a collaborative partnership with Bayer HealthCare AG for the treatment of serious infections.

Outside the antibacterial therapeutic area, Paratek has also established an internal effort to exploit its novel families of compounds and their unique mechanism of action in selected anti-inflammatory and neurodegenerative conditions. Paratek has an active chemical synthesis effort to produce novel and diverse small molecules, with the goal of developing non-antibacterial products with improved activity in serious diseases based upon a growing body of clinical and basic research supporting this approach.

Paratek is privately held and headquartered in Boston, Massachusetts, USA. For more information, visit Paratek's website at http://www.paratekpharm.com

Multiple Sclerosis - Paratek is developing orally available non-antibacterial tetracyclines for the treatment of multiple sclerosis (MS). These compounds are disease modifying agents to reduce demyelination, relapses and progression in patients suffering from various forms of MS, including relapsing and remitting MS. This effort follows the recent publication of very favorable clinical data with minocycline (reference 26). Paratek’s novel compounds offer the potential to show improved activity but without the side effects associated with broad spectrum antibiotics, which can be a problem with long-term use of minocycline. Paratek established a Collaborative Research and License Agreement with Serono SA in October 2004 to develop novel and improved tetracycline derived compounds for MS. Paratek presented data on its novel non-antibacterial tetracycline derivatives in the EAE model in October 2004 Lead candidate compounds for preclinical development are expected to be designated by mid 2006.
The second stage of MS -THE NEURODEGENERATIVE STAGE - where the excess glutamate kills neurons.

http://home.ix.netcom.com/~jdalton/ms-two-stages.pdf

Below pic/chart is from this report. NOTE EXCESS GLUTAMATE

jackD is offline   Reply With QuoteReply With Quote
Old 06-26-2008, 05:51 PM #40
karilann's Avatar
karilann karilann is offline
Member
 
Join Date: Sep 2006
Location: Northern Michigan...Upper Peninsula
Posts: 625
15 yr Member
karilann karilann is offline
Member
karilann's Avatar
 
Join Date: Sep 2006
Location: Northern Michigan...Upper Peninsula
Posts: 625
15 yr Member
Default vitamin D3

I asked my doc to check my levels and they were excessively low. She put me on the mega dose for awhile and now I take 1000IU a day to maintain. I don't feel any different, but I do believe no one should have low levels of anything without paying consequences later on.
I grew up in Michigan so enough said.
Perhaps people with low vit D levels get sick....or maybe sick people develope low levels of vit D.....I'm not sure...but getting your levels up is optimal.
__________________

.
If you obsess about things that may happen and they don't come true...then you've wasted your time. If it does come true....then you've lived it twice.
.
karilann is offline   Reply With QuoteReply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
So should i or should i not take b12 vitamin? Monica de Lara Peripheral Neuropathy 24 01-12-2012 05:41 AM
Mrs D - Vitamin Help? BEGLET Peripheral Neuropathy 22 02-10-2008 07:00 PM
Vitamin C? daniella Vitamins, Nutrients, Herbs and Supplements 9 12-08-2007 05:50 PM
Vitamin A carolyn_lsc Vitamins, Nutrients, Herbs and Supplements 5 12-05-2006 01:26 PM
Vitamin D and RSD? Noble Reflex Sympathetic Dystrophy (RSD and CRPS) 1 10-05-2006 04:00 AM


All times are GMT -5. The time now is 06:22 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.